Presentation TCT 2019 EVOLVE Short DAPT: A Single-Arm Study of 3-Month DAPT in Patients at High Bleeding Risk Treated With a Bioabsorbable Polymer-Based Everolimus-Eluting Stent Presenter: Ajay Kirtane September 26, 2019
News Conference News TCT 2019 IDEAL-LM Probes Short DAPT and a Bioabsorbable-Polymer Stent in Left Main Disease Michael O'Riordan September 26, 2019
Presentation TCT 2019 Case Resolution: How Did I Treat and What Happened? Presenter: Amit Vora September 26, 2019
Presentation TCT 2019 The Approach to the High Bleeding Risk Patient: The Dos and the Don’ts! Presenter: Bernard Chevalier September 26, 2019
Presentation TCT 2019 Long-Term Antithrombotic Therapy After PCI: How Do I Incorporate COMPASS Into My Practice? Presenter: Robert Welsh September 26, 2019
Presentation TCT 2019 De-Escalation: When and How? — The Role of Platelet Function and Genetic Testing Presenter: Francesco Franchi September 26, 2019
News Conference News TCT 2019 TWILIGHT: Ticagrelor Monotherapy Lowers Bleeding Without Increasing Ischemic Events Yael L. Maxwell September 26, 2019
Presentation TCT 2019 Insights From GLOBAL LEADERS and GLASSY Presenter: Pascal Vranckx September 26, 2019
Presentation TCT 2019 Short and Ultrashort DAPT Strategies After Stent Implantation: What Do We Know and Where Are We Going? Presenter: Robert Byrne September 26, 2019
Presentation TCT 2019 Case Introduction: DAPT Dilemma After a Complex PCI in a High Bleeding Risk Patient Presenter: Amit Vora September 26, 2019
Presentation TCT 2019 Case Resolution: How Did I Treat This Patient? Presenter: Nerin Okasha September 25, 2019
Presentation TCT 2019 Case 5 (From Malaysia): Hybrid Approach in Diffuse Coronary Artery Disease Presenter: Kenneth Chin September 25, 2019
Presentation TCT 2019 TCT 26: Predictors of Bailout Rotational Atherectomy in Patients With Complex Calcified Coronary Artery Disease: A Pooled Analysis From the Randomized ROTAXUS and PREPARE-CALC Trials Presenter: Mohamed Abdel-Wahab September 25, 2019
News Industry News CeleCor Therapeutics Announces Positive First-in-Human Data of RUC-4, a Novel Subcutaneous Platelet GPIIb/IIIa Inhibitor, Presented at TCT 2019 September 25, 2019
News Analysis Hints at Survival Benefit With Revascularization in Stable Patients With Myocardial Ischemia Michael O'Riordan September 24, 2019